Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 1
1991 3
1993 2
1994 4
1995 2
1997 2
1998 4
2000 3
2001 11
2002 12
2003 11
2004 8
2005 5
2006 5
2007 8
2008 4
2009 7
2010 5
2011 11
2012 13
2013 22
2014 25
2015 15
2016 18
2017 23
2018 18
2019 22
2020 25
2021 35
2022 28
2023 20
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Beyond PI-RADS: Combining MRI PI-RADS and PSMA-PET/CT PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.
Emmett L, Papa N, Hope TA, Fendler W, Calais J, Burger I, Eiber M, Barbato F, Moon D, Counter W, John N, Xue A, Franklin A, Thompson J, Rasiah K, Frydenberg M, Yaxley J, Buteau J, Agrawal S, Ho B, Nguyen A, Liu V, Lee J, Woo H, Hsiao E, Sutherland T, Perry E, Stricker P, Hofman MS, Kasivisvanathan V, Roberts M, Murphy D. Emmett L, et al. Among authors: frydenberg m. J Urol. 2024 May 17:101097JU0000000000004010. doi: 10.1097/JU.0000000000004010. Online ahead of print. J Urol. 2024. PMID: 38758680
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis.
Lindsay D, Schofield P, Nabukalu D, Roberts MJ, Yaxley J, Quinn S, Richards N, Frydenberg M, Gardiner R, Lawrentschuk N, Juraskova I, Murphy DG, Gordon LG. Lindsay D, et al. Among authors: frydenberg m. Aust Health Rev. 2024 Feb;48:AH23231. doi: 10.1071/AH23231. Aust Health Rev. 2024. PMID: 38342484 Clinical Trial.
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer.
Buteau JP, Moon D, Fahey MT, Roberts MJ, Thompson J, Murphy DG, Papa N, Mitchell C, De Abreu Lourenco R, Dhillon HM, Kasivisvanathan V, Francis RJ, Stricker P, Agrawal S, O'Brien J, McVey A, Sharma G, Levy S, Ayati N, Nguyen A, Lee SF, Pattison DA, Sivaratnam D, Frydenberg M, Du Y, Titus J, Lee ST, Ischia J, Jack G, Hofman MS, Emmett L. Buteau JP, et al. Among authors: frydenberg m. Eur Urol Oncol. 2024 Jun;7(3):544-552. doi: 10.1016/j.euo.2023.11.008. Epub 2023 Dec 6. Eur Urol Oncol. 2024. PMID: 38061976 Free article. Clinical Trial.
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, Gianduzzo T, Kua B, Ho B, Nguyen A, Liu V, Lee J, Hsiao E, Sutherland T, Perry E, Fendler WP, Hope TA. Emmett L, et al. Among authors: frydenberg m. J Nucl Med. 2024 Jan 2;65(1):94-99. doi: 10.2967/jnumed.123.266164. J Nucl Med. 2024. PMID: 38050155
68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study.
Gondoputro W, Doan P, Katelaris A, Scheltema MJ, Geboers B, Agrawal S, Liu Z, Yaxley J, Savdie R, Rasiah K, Frydenberg M, Roberts MJ, Malouf D, Wong D, Shnier R, Delprado W, Emmett L, Stricker PD, Thompson J. Gondoputro W, et al. Among authors: frydenberg m. Transl Androl Urol. 2023 Oct 31;12(10):1598-1606. doi: 10.21037/tau-22-708. Epub 2023 Oct 7. Transl Androl Urol. 2023. PMID: 37969779 Free PMC article.
Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.
Garin O, Kowalski C, Zamora V, Roth R, Ferrer M, Breidenbach C, Pont A, Belin TR, Elashoff D, Wilhalme H, Nguyen AV, Kwan L, Pearman EK, Bolagani A, Sampurno F, Papa N, Moore C, Millar J, Connor SE, Villanti P, Litwin MS; True North Global Registry. Garin O, et al. BMC Urol. 2023 Nov 3;23(1):178. doi: 10.1186/s12894-023-01344-0. BMC Urol. 2023. PMID: 37919726 Free PMC article.
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy.
Kelly BD, Ptasznik G, Roberts MJ, Doan P, Stricker P, Thompson J, Buteau J, Chen K, Alghazo O, O'Brien JS, Hofman MS, Frydenberg M, Lawrentschuk N, Lundon D, Murphy DG, Emmett L, Moon D. Kelly BD, et al. Among authors: frydenberg m. Eur Urol Open Sci. 2023 Jun 2;53:90-97. doi: 10.1016/j.euros.2023.05.002. eCollection 2023 Jul. Eur Urol Open Sci. 2023. PMID: 37441340 Free PMC article.
336 results